Head-to-head · WeighScore
Lttl vs telos rx
By GLP-1 ScorecardUpdated
Score comparison
telos rx has the higher recorded score — 85.4/100 to 63.5/100.
telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers injectable and oral compounded GLP-1 options. Our August pricing check found that the $49 oral promotion covered the first month; renewal pricing and the prepaid billing period matter more than that headline.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Lttl | telos rx |
|---|---|---|
| WeighScore | 63.5/100 | 85.4/100 |
| Grade | C | B |
| Site position | #210 | #14 |
| Semaglutide | $99/mo monthly auto-refill; $89/mo equivalent billed $1,068 annually (confirm supply/renewal) | $99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks |
| Tirzepatide | $149/mo monthly auto-refill; $139/mo equivalent billed $1,668 annually (confirm supply/renewal) | $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) |
| Coverage | Provider claims 50 states + DC; treatment availability varies | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #210 · C
Strengths
- Public ordinary monthly injection rates of $99 semaglutide and $149 tirzepatide, with longer-plan charges disclosed separately
- The plan selector identifies supply lengths, including four weeks for monthly auto-refill and 52 weeks annually
- Four possible dispensing pharmacies are named in the terms, without an individual assignment established
- Microdose injection and oral-tablet selector entries provide additional options to discuss with a clinician; availability and clinical suitability require confirmation
What to consider
- Monthly, quarterly and six-month supply labels do not align with calendar-month language; confirm actual refill and debit intervals
- Medical-rejection refund language conflicts with consultation-fee retention wording
- Terms use medical intake as a nonrefund boundary, while support uses pharmacy processing/shipping; refund deadlines also differ
- The assigned treating practice, prescriber and actual dispensing location remain unestablished
- Branded-service exceptions are described, but no available brand-specific prescription or price was established
- A 48-hour shipping headline differs from the policy estimate of two to five business days processing plus three to seven in transit
Site position #14 · B
Strengths
- Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
- Needle-free and oral GLP-1 options, not injection-only
- LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
- Our August check recorded injectable semaglutide at $99/month, injectable tirzepatide at $139/month, and microdosed tirzepatide at $116/month
What to consider
- Everything is compounded and not FDA-approved, including the peptides
- The $49 oral offer is introductory; the recorded renewal is $129/month billed every 48 weeks. Check the total prepaid charge and renewal terms
- No named clinicians and thin third-party reviews
- Several research-grade peptides carry limited clinical evidence
Featured provider
Lttl
Lttl scores 63.5/100 (C). Lttl publishes monthly and longer compounded-injection offers plus a low-dose and oral menu; compare the actual charge and supply interval because annual equivalents and four-week labels describe different commitments.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.